Genetic Association Analysis of NOS3 and Methamphetamine-Induced Psychosis Among Japanese
- PMID: 21886581
- PMCID: PMC3137171
- DOI: 10.2174/157015911795017119
Genetic Association Analysis of NOS3 and Methamphetamine-Induced Psychosis Among Japanese
Abstract
Endothelial nitric oxide synthase (NOS3) is one of the enzymes influencing nitric oxide (NO) function in the human brain. NO is a gaseous neurotransmitter that is involved in a variety of mechanisms in the central nervous system, such as N-methyl-D-aspartate receptor activation and oxidative stress. The evidence from animal pharmacological studies and postmortem studies supports an association between NO and psychotic disorders. Methamphetamine (METH) use disorder is a known psychotic disorder, and we therefore conducted a gene-based case-control study between tagging single nucleotide polymorphisms (SNPs) (rs2070744, rs1799983) in NOS3 and METH-induced psychosis in Japanese subjects (183 with METH-induced psychosis and 267 controls). Written informed consent was obtained from each subject. No significant association was found between any tagging SNP in NOS3 and METH-induced psychosis in the allele/genotype-wise or haplotype-wise analyses. In conclusion, we suggest that NOS3 might not contribute to the risk of METH-induced psychosis in the Japanese population.
Keywords: Methamphetamine-induced psychosis; endothelial nitric oxide synthase (NOS3); gene-based case-control association study..
References
-
- Munzar P, Tanda G, Justinova Z, Goldberg SR. Histamine h3 receptor antagonists potentiate methamphetamine self-administration and methamphetamine-induced accumbal dopamine release. Neuropsychopharmacology. 2004;29:705–717. - PubMed
-
- Vocci FJ, Acri J, Elkashef A. Medication development for addictive disorders: the state of the science. Am. J. Psychiatry. 2005;162:1432–1440. - PubMed
-
- Anderson KL, Itzhak Y. Methamphetamine-induced selective dopaminergic neurotoxicity is accompanied by an increase in striatal nitrate in the mouse. Ann. N.Y. Acad. Sci. 2006;1074:225–233. - PubMed
-
- Snyder SH, Ferris CD. Novel neurotransmitters and their neuropsychiatric relevance. Am. J. Psychiatry. 2000;157:1738–1751. - PubMed
-
- Yao JK, Reddy RD. Metabolic investigation in psychiatric disorders. Mol. Neurobiol. 2005;31:193–203. - PubMed
LinkOut - more resources
Full Text Sources